Cargando…

Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience

Background: Behavioral and psychological symptoms of dementia (BPSD) are a distressful condition. We aimed to investigate the BPSD distribution in subjects with cognitive impairment, and the potential correlations between BPSD and neurodegeneration in terms of cerebrospinal fluid (CSF) tau and brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotta Ramusino, Matteo, Perini, Giulia, Vaghi, Gloria, Dal Fabbro, Beatrice, Capelli, Marco, Picascia, Marta, Franciotta, Diego, Farina, Lisa, Ballante, Elena, Costa, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973017/
https://www.ncbi.nlm.nih.gov/pubmed/33746732
http://dx.doi.org/10.3389/fnagi.2021.595758
_version_ 1783666757328699392
author Cotta Ramusino, Matteo
Perini, Giulia
Vaghi, Gloria
Dal Fabbro, Beatrice
Capelli, Marco
Picascia, Marta
Franciotta, Diego
Farina, Lisa
Ballante, Elena
Costa, Alfredo
author_facet Cotta Ramusino, Matteo
Perini, Giulia
Vaghi, Gloria
Dal Fabbro, Beatrice
Capelli, Marco
Picascia, Marta
Franciotta, Diego
Farina, Lisa
Ballante, Elena
Costa, Alfredo
author_sort Cotta Ramusino, Matteo
collection PubMed
description Background: Behavioral and psychological symptoms of dementia (BPSD) are a distressful condition. We aimed to investigate the BPSD distribution in subjects with cognitive impairment, and the potential correlations between BPSD and neurodegeneration in terms of cerebrospinal fluid (CSF) tau and brain atrophy. Methods: One-hundred patients with mild cognitive impairment (MCI) or dementia (Alzheimer’s disease, AD; Lewy-body disease, LBD; frontotemporal dementia, FTD; vascular dementia, VD) underwent a complete diagnostic workup, including 3T-MRI and/or CT and CSF. Cortical atrophy was assessed with medial temporal atrophy (MTA), posterior atrophy (PA), and global cortical atrophy-frontal lobe (GCA-F) scales. BPSD were rated using the Neuropsychiatric Inventory (NPI), and BPSD clusters were defined according to the European Alzheimer Disease Consortium. Results: Delusions, hallucinations, and psychosis cluster were differently distributed among the diagnostic groups (p < 0.05, p < 0.001, and p < 0.05), with LBD patients showing higher scores for hallucinations (vs. MCI, p < 0.001, and AD, p < 0.05) and psychosis cluster (vs. MCI, p < 0.05). In primary dementias, we found a negative correlation between NPI total score and tau levels (p = 0.08), confirmed by beta regression (p < 0.01), while a positive non-significant relationship was observed in MCI. Higher GCA-F scores were associated with delusions and apathy (p < 0.05, on both hemispheres) and hallucinations (left: p < 0.01, right: p < 0.05). GCA-F scores were positively correlated with psychosis cluster (right: p < 0.05), and agitation/aggression (left: p < 0.05). Conversely, nighttime disturbances were positively correlated with both GCA-F and MTA scores (left: p < 0.01; right: p < 0.05). Conclusion: Our results suggest that psychotic symptoms are significantly more represented in LBD patients and that CSF tau and frontal atrophy are associated with the occurrence and severity of BPSD in clinical practice. Longitudinal studies are however required to ascertain their actual predictive value.
format Online
Article
Text
id pubmed-7973017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79730172021-03-20 Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience Cotta Ramusino, Matteo Perini, Giulia Vaghi, Gloria Dal Fabbro, Beatrice Capelli, Marco Picascia, Marta Franciotta, Diego Farina, Lisa Ballante, Elena Costa, Alfredo Front Aging Neurosci Neuroscience Background: Behavioral and psychological symptoms of dementia (BPSD) are a distressful condition. We aimed to investigate the BPSD distribution in subjects with cognitive impairment, and the potential correlations between BPSD and neurodegeneration in terms of cerebrospinal fluid (CSF) tau and brain atrophy. Methods: One-hundred patients with mild cognitive impairment (MCI) or dementia (Alzheimer’s disease, AD; Lewy-body disease, LBD; frontotemporal dementia, FTD; vascular dementia, VD) underwent a complete diagnostic workup, including 3T-MRI and/or CT and CSF. Cortical atrophy was assessed with medial temporal atrophy (MTA), posterior atrophy (PA), and global cortical atrophy-frontal lobe (GCA-F) scales. BPSD were rated using the Neuropsychiatric Inventory (NPI), and BPSD clusters were defined according to the European Alzheimer Disease Consortium. Results: Delusions, hallucinations, and psychosis cluster were differently distributed among the diagnostic groups (p < 0.05, p < 0.001, and p < 0.05), with LBD patients showing higher scores for hallucinations (vs. MCI, p < 0.001, and AD, p < 0.05) and psychosis cluster (vs. MCI, p < 0.05). In primary dementias, we found a negative correlation between NPI total score and tau levels (p = 0.08), confirmed by beta regression (p < 0.01), while a positive non-significant relationship was observed in MCI. Higher GCA-F scores were associated with delusions and apathy (p < 0.05, on both hemispheres) and hallucinations (left: p < 0.01, right: p < 0.05). GCA-F scores were positively correlated with psychosis cluster (right: p < 0.05), and agitation/aggression (left: p < 0.05). Conversely, nighttime disturbances were positively correlated with both GCA-F and MTA scores (left: p < 0.01; right: p < 0.05). Conclusion: Our results suggest that psychotic symptoms are significantly more represented in LBD patients and that CSF tau and frontal atrophy are associated with the occurrence and severity of BPSD in clinical practice. Longitudinal studies are however required to ascertain their actual predictive value. Frontiers Media S.A. 2021-03-05 /pmc/articles/PMC7973017/ /pubmed/33746732 http://dx.doi.org/10.3389/fnagi.2021.595758 Text en Copyright © 2021 Cotta Ramusino, Perini, Vaghi, Dal Fabbro, Capelli, Picascia, Franciotta, Farina, Ballante and Costa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Cotta Ramusino, Matteo
Perini, Giulia
Vaghi, Gloria
Dal Fabbro, Beatrice
Capelli, Marco
Picascia, Marta
Franciotta, Diego
Farina, Lisa
Ballante, Elena
Costa, Alfredo
Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
title Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
title_full Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
title_fullStr Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
title_full_unstemmed Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
title_short Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
title_sort correlation of frontal atrophy and csf tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973017/
https://www.ncbi.nlm.nih.gov/pubmed/33746732
http://dx.doi.org/10.3389/fnagi.2021.595758
work_keys_str_mv AT cottaramusinomatteo correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT perinigiulia correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT vaghigloria correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT dalfabbrobeatrice correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT capellimarco correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT picasciamarta correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT franciottadiego correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT farinalisa correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT ballanteelena correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience
AT costaalfredo correlationoffrontalatrophyandcsftaulevelswithneuropsychiatricsymptomsinpatientswithcognitiveimpairmentamemoryclinicexperience